Nuvalent, Inc.
🏢 View company profile →6Patents
6Active
6Granted
59Portfolio score
Filing activity: Oct 29, 2021 → Sep 30, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11542278B1 | Heteroaromatic macrocyclic ether chemotherapeutic agents | Chemistry; Metallurgy | 4 | Active |
| US11667649B2 | Heteroaromatic macrocyclic ether chemotherapeutic agents | Chemistry; Metallurgy | 3 | Active |
| US12043626B2 | Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether compounds | Chemistry; Metallurgy | 0 | Active |
| US12275742B2 | Heteroaromatic macrocyclic ether chemotherapeutic agents | Chemistry; Metallurgy | 0 | Active |
| US12054498B2 | Heteroaromatic macrocyclic ether chemotherapeutic agents | Chemistry; Metallurgy | 0 | Active |
| US12037346B2 | Amino-substituted heteroaryls for treating cancers with EGFR mutations | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.